Viewing StudyNCT04337931



Ignite Creation Date: 2024-05-06 @ 2:30 PM
Last Modification Date: 2024-10-26 @ 1:32 PM
Study NCT ID: NCT04337931
Status: TERMINATED
Last Update Posted: 2024-02-13
First Post: 2020-03-30

Brief Title: A Study to Evaluate Sotigalimab APX005M in Subjects With Unresectable or Metastatic Melanoma
Sponsor: Apexigen America Inc
Organization: Apexigen America Inc

Conditions & Keywords Data

Conditions:
Name
Melanoma Skin
Unresectable Melanoma
Metastatic Melanoma
Cancer
Cancer of Skin
Melanoma
Keywords:
Name View
CD40 View
Immunotherapy View
APX005M View
sotigalimab View